These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A review of the clinical progress on helminths and their derivative products in autoimmune disease]. Wu X; Gao H; Duan S; Ding W; Yang X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1132-1140. PubMed ID: 38140874 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials of helminth therapy in autoimmune diseases: rationale and findings. Fleming JO; Weinstock JV Parasite Immunol; 2015 Jun; 37(6):277-92. PubMed ID: 25600983 [TBL] [Abstract][Full Text] [Related]
5. Human helminth therapy to treat inflammatory disorders - where do we stand? Helmby H BMC Immunol; 2015 Mar; 16():12. PubMed ID: 25884706 [TBL] [Abstract][Full Text] [Related]
6. [Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases]. Sega Y; Versini M; Shoenfeld Y Harefuah; 2015 Jul; 154(7):428-31, 470, 469. PubMed ID: 26380461 [TBL] [Abstract][Full Text] [Related]
7. Exosome-transported microRNAs of helminth origin: new tools for allergic and autoimmune diseases therapy? Siles-Lucas M; Morchon R; Simon F; Manzano-Roman R Parasite Immunol; 2015 Apr; 37(4):208-14. PubMed ID: 25712154 [TBL] [Abstract][Full Text] [Related]
8. Helminths: a clinical review and update. Prickett KA; Ferringer TC Semin Cutan Med Surg; 2014 Sep; 33(3):128-32. PubMed ID: 25577852 [TBL] [Abstract][Full Text] [Related]
9. Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect. Voldsgaard A; Bager P; Garde E; Åkeson P; Leffers AM; Madsen CG; Kapel C; Roepstorff A; Thamsborg SM; Melbye M; Siebner H; Søndergaard HB; Sellebjerg F; Sørensen PS Mult Scler; 2015 Nov; 21(13):1723-9. PubMed ID: 25698173 [TBL] [Abstract][Full Text] [Related]
10. A novel regulatory macrophage induced by a helminth molecule instructs IL-10 in CD4+ T cells and protects against mucosal inflammation. Ziegler T; Rausch S; Steinfelder S; Klotz C; Hepworth MR; Kühl AA; Burda PC; Lucius R; Hartmann S J Immunol; 2015 Feb; 194(4):1555-64. PubMed ID: 25589067 [TBL] [Abstract][Full Text] [Related]
11. Optimizing the use of biological therapy in patients with inflammatory bowel disease. Moss AC Gastroenterol Rep (Oxf); 2015 Feb; 3(1):63-8. PubMed ID: 25567472 [TBL] [Abstract][Full Text] [Related]
12. [Recommendations from the Brazilian Society of Rheumatology on the diagnosis and treatment of intestinal parasitic infections in patients with autoimmune rheumatic disorders]. Braz AS; de Andrade CA; da Mota LM; Lima CM Rev Bras Reumatol; 2015; 55(4):368-80. PubMed ID: 25583002 [TBL] [Abstract][Full Text] [Related]